Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
Recruiting · NCT05407168 · Interventional (participants receive a specific treatment) · Lead sponsor: OHSU Knight Cancer Institute
View the official record on ClinicalTrials.gov →Interventions studied
Best PracticeHealth Promotion and EducationQuestionnaire Administration
What this trial is about
This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.
Who can take part
Age range
18 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- AIM 1: Suspected lung cancer
- AIM 1: English fluency
- AIM 1: \> 6-month life expectancy
- AIM 1: Score of ≥ 3 on the cognitive impairment screener
- AIM 2 PARTICIPANTS: Participation in Aim 1
- AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants
Where it is running
4 locations listed across 1 US state.
- Hillsboro Medical Center - Hillsboro, Oregon, United States
- Adventist Health Portland - Portland, Oregon, United States
- OHSU Knight Cancer Institute - Portland, Oregon, United States
- Portland VA Medical Center - Portland, Oregon, United States